Literature DB >> 9171814

Remission of self-mutilation in a patient with borderline personality during risperidone therapy.

H R Khouzam1, N J Donnelly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171814     DOI: 10.1097/00005053-199705000-00011

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  8 in total

Review 1.  Psychopharmacology of personality disorders: review and emerging issues.

Authors:  P S Links; A Boggild; N Sarin
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

2.  Self-mutilation and pharmacotherapy.

Authors:  Brian Daniel Smith
Journal:  Psychiatry (Edgmont)       Date:  2005-10

Review 3.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 4.  Impulsive aggression in borderline personality disorder.

Authors:  M Goodman; A New
Journal:  Curr Psychiatry Rep       Date:  2000-02       Impact factor: 5.285

Review 5.  Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Authors:  Silvio Bellino; Erika Paradiso; Filippo Bogetto
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment.

Authors:  Hasan Belli; Cenk Ural; Mahir Akbudak
Journal:  J Clin Med Res       Date:  2012-09-12

Review 7.  Medications in the treatment of borderline personality disorder 2006.

Authors:  Deanna Mercer
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 8.081

8.  Off-label indications for atypical antipsychotics: A systematic review.

Authors:  Konstantinos N Fountoulakis; Ioannis Nimatoudis; Apostolos Iacovides; George Kaprinis
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-02-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.